Landscape of Top Competitors and Glioblastoma Multiforme Treatment Market Size Insights
The global Glioblastoma Multiforme (GBM) treatment market is poised for significant growth and is expected to reach a valuation of USD 4.82 billion by 2030, expanding at a compound annual growth rate (CAGR) of 8.9% during the forecast period. This upward trajectory is driven by rising incidences of brain tumors, increasing awareness about GBM, advancements in therapeutic technologies,...
0 Commenti 0 condivisioni 51 Views 0 Anteprima